@FierceMedDev: Teleflex has closed the $45.2M sale of its ortho unit to Tecomet. News | Follow @FierceMedDev
@MarkHFierce: We have a great roster of new stories this week in FierceBiotechResearch. Check them out! More | Follow @MarkHFierce
@DamianFierce: Two congressional Democrats want the FDA to keep closer tabs on 510(k) applicants. More | Follow @DamianFierce
> According to a Cutting Edge Information study, medical device firms spent 24% less on their compliance teams in 2012 than in the previous year, making them victims of industry-wide cost-cutting. More
> Positron, through its joint venture with Neusoft Medical Systems, snagged a CE mark for its Attrius PET system. News
> And, speaking of Positron, the company secured a placement for one of its molecular imaging systems, as a New Jersey hospital has begun to use the Amyvid PET scan to detect brain plaque, a precursor to Alzheimer's. Item
> The Netherlands' EndoStim got a CE mark for its LES stimulation system, designed to treat gastro-esophageal reflux disease. Release
> As you brave the dog days of summer and its attendant bug bites, the FDA-cleared Therapik device may be of use. The handheld tech uses directed heat to alleviate the pain and itch of insect bites, and, according to Gizmodo, the thing actually works. Story
Biotech News
@FierceBiotech: Geron generates spark from cancer pipeline. News | Related report by @MarkHFierce: Report | Follow @FierceBiotech
@JohnCFierce: CRO market headed to $1B in India according to Frost & Sullivan. Report | Follow @JohnCFierce
@RyanMFierce: Yes, the Farber doc did say "mouse's mojo." But the study of rodents', ah, zest could pave way to "the pill" for guys. More | Follow @RyanMFierce
> Gene patent ruling seen as win for Myriad, biotech industry. Story
> Harvard docs happen upon potential male birth control with cancer compound. Article
> Quintiles cozies up to Eli Lilly with new Indy office. Story
> GSK runs to PhIII with upbeat data on drug for severe asthma. More
Pharma News
@FiercePharma: China's animal health market is growing doggone fast. Bayer, Sanofi, etc. aim to take advantage--Bloomberg. Report | Follow @FiercePharma
> Takeda's Actos era ends with generic launches. Story
> Pfizer, Hospira likely shoppers for Indian injectables star Agila. Report
> Cinven to pay $732M for U.K.'s Mercury Pharma. News